Product
TRIIM Treatment
1 clinical trial
2 indications
Indication
Epigenetic AgingIndication
ImmunosenescenceClinical trial
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension TrialStatus: Recruiting, Estimated PCD: 2024-11-01